We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTSH icon
426
Cognizant
CTSH
$25.2B
$3.88M 0.03%
67,787
-8,075
-11% -$474K
SHOP icon
427
Shopify
SHOP
$168B
$3.87M 0.03%
111,595
-15,397
-12% -$526K
GPC icon
428
Genuine Parts
GPC
$17.9B
$3.87M 0.03%
22,287
+14,279
+178% +$2.48M
VRSK icon
429
Verisk Analytics
VRSK
$27.7B
$3.85M 0.03%
21,846
-928
-4% -$163K
WBA
430
DELISTED
Walgreens Boots Alliance
WBA
$3.82M 0.03%
102,233
-6,420
-6% -$241K
TME icon
431
Tencent Music
TME
$15.9B
$3.81M 0.03%
+460,000
New +$2.58M
TTWO icon
432
Take-Two Interactive
TTWO
$46.1B
$3.71M 0.03%
35,619
-2,368
-6% -$256K
MGI
433
DELISTED
MoneyGram International, Inc. New
MGI
$3.68M 0.02%
337,549
CMI icon
434
Cummins
CMI
$83.6B
$3.67M 0.02%
15,156
-457
-3% -$109K
KIDS icon
435
OrthoPediatrics
KIDS
$513M
$3.65M 0.02%
91,991
ONT
436
Onterris Inc
ONT
$731M
$3.65M 0.02%
+82,221
New +$3.48M
XRAY icon
437
Dentsply Sirona
XRAY
$2.84B
$3.6M 0.02%
112,946
-4,587
-4% -$138K
NUE icon
438
Nucor
NUE
$58.3B
$3.59M 0.02%
27,275
-1,187
-4% -$161K
F icon
439
Ford
F
$60.9B
$3.53M 0.02%
303,313
-10,610
-3% -$136K
COO icon
440
Cooper Companies
COO
$14.2B
$3.53M 0.02%
42,656
+5,104
+14% +$377K
BXP icon
441
Boston Properties
BXP
$11.6B
$3.52M 0.02%
52,121
-7,409
-12% -$525K
DLR icon
442
Digital Realty Trust
DLR
$69.6B
$3.52M 0.02%
35,065
-4,092
-10% -$418K
RF icon
443
Regions Financial
RF
$26.4B
$3.5M 0.02%
162,198
-60,112
-27% -$1.3M
IEX icon
444
IDEX
IEX
$17B
$3.49M 0.02%
15,283
-1,174
-7% -$262K
PSX icon
445
Phillips 66
PSX
$82.9B
$3.48M 0.02%
33,455
+76
+0.2% +$7.77K
BMI icon
446
Badger Meter
BMI
$3.87B
$3.46M 0.02%
31,732
-21,046
-40% -$2.29M
HPE icon
447
Hewlett Packard
HPE
$58.8B
$3.44M 0.02%
215,716
-22,818
-10% -$336K
HAS icon
448
Hasbro
HAS
$13.5B
$3.43M 0.02%
56,239
-307,586
-85% -$19.2M
CFG icon
449
Citizens Financial Group
CFG
$30.1B
$3.42M 0.02%
86,769
-7,728
-8% -$302K
HES
450
DELISTED
Hess
HES
$3.4M 0.02%
23,977
-97,196
-80% -$13.4M

Similar funds

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.